(Q45828252)

English

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

scientific article published in April 1985

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Omata M

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Imazeki F

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Yokosuka O

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Ito Y

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Uchiumi K

5

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Mori J

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Okuda K

7

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

language of work or name

0 references

publication date

1 April 1985

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

88

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

870-880

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Synthesis in E. coli of a polypeptide with human leukocyte interferon activity

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Human leukocyte interferon produced by E. coli is biologically active

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA and DNA polymerase in the core of the Dane particle of hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to human leucocyte interferons in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Large-scale Production of Human Leukocyte Interferon Containing 108 Units per ml

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of hybridomas secreting monoclonal antibodies to the human leukocyte interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of human fibroblast interferon in chronic hepatitis-B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon Treatment in Acute Hepatitis b Infection with Prolonged Course

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibroblast interferon treatment of a patient with chronic active hepatitis. Increased number of circulating T lymphocytes and elimination of rosette-inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2885%2980002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0016-5085(85)80002-0

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/3972231

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45828252&oldid=2143534032"